. Third,
While these biochemical experiments are suggestive, their relevance for synaptic plasticity remains undetermined. Thus, we have performed whole-cell patch clamp recordings and microfluorimetric Ca 2ϩ imaging of cerebellar Purkinje cells in culture together with manipulations to modify the interactions between GluR2/3, GRIP/ ABP, and PICK1. In so doing, we sought to test the hypothesis that LTD expression is achieved by phosphorylation of GluR2 at Ser-880 (or GluR3 at the analogous residue, Ser-885) by PKC, which regulates the interaction of GluR2 with GRIP/ABP and PICK1, thereby priming AMPA receptors for clathrin-mediated endocytosis. . SVKI peptide produced a very small decrease in evoked AMPA currents that became stable ‫51ف‬ min external saline, and V hold was set to Ϫ50 mV. The following peptides were added to the internal saline at a confollowing the beginning of whole-cell recording (90% Ϯ 5% of baseline at t ϭ 15 min, mean Ϯ SEM, n ϭ 7). This amplitude of evoked NMDA currents (SVKI: 102% Ϯ 4% of baseline at t ϭ 15 min; SGKA: 100% Ϯ 3% of baseline; decrease was not significant (p Ͼ 0.05 by Student's t test) when compared with that produced by the control SVAI: 101% Ϯ 4% of baseline; phospho-SVKI: 101% Ϯ 4% of baseline). peptide SGKA (102% Ϯ 4% of baseline at t ϭ 15 min, n ϭ 6). SVAI and phospho-SVKI peptides also failed to While the four peptides based on the GluR2 PDZ binding motif do not significantly affect the responses to significantly affect basal AMPA responses (101% Ϯ 4% of baseline at t ϭ 15 min, n ϭ 5, and 95% Ϯ 5% of exogenous test pulses of AMPA (or NMDA), it remains possible that exogenously applied agonists could actibaseline at t ϭ 15 min, n ϭ 5, respectively). None of the four peptides produced significant alterations in the vate a higher proportion of extrasynaptic receptors than g/ml, n ϭ 5), the GST backbone protein (GST backbone, 50 g/ml, n ϭ 4), a mutant GST-PICK1 fusion protein with a deletion of the coiled-coil multimerization domain (GST-PICK1⌬CC; 50 and 150 g/ml, n ϭ 7 and 5, respectively), and a mutant GST-PICK1 fusion protein in which the PDZ domain had been rendered nonfunctional (GST-PICK1⌬PDZ, 50 g/ml, n ϭ 6).
Results

Initially
nal PDZ binding motif. To accomplish this, we applied be required to induce LTD. As an initial test of this hypothesis, mutant GST-PICK1 fusion proteins were SVAI peptide, which interferes with PICK1-GRIP/ABPGluR2/3 interactions but is not a substrate for PKC. of baseline at t ϭ 17.5 min, n ϭ 7 and 5, respectively) when compared with two controls, wild-type GST-PICK1 Infusion of phospho-SVKI peptide also produced a strong blockade of LTD (90% Ϯ 8% of baseline at t ϭ (GST-PICK1, 50 g/ml, 104% Ϯ 5% of baseline, n ϭ 5) and the GST backbone (GST backbone, 50 mg/ml, 50 min, n ϭ 7).
The finding that infusion of phospho-SVKI peptide 96% Ϯ 5% of baseline, n ϭ 4). However, perfusion of GST-PICK1⌬CC did result in an attenuation of subseblocked cerebellar LTD induction suggests that the binding of GluR2/3 to PICK1, but not GRIP/ABP, is requently induced LTD (GST-PICK1⌬CC; 50 and 150 g/ml, 91% Ϯ 10% and 89% Ϯ 10% of baseline at quired. To provide a further test of this idea, we internally perfused an affinity-purified antiserum directed against t ϭ 55 min, respectively) as compared with GST-PICK1 (59% Ϯ 9% of baseline) and GST backbone (52% Ϯ the amino-terminal PDZ domain of rat PICK1 (anti-N-PICK1, 20 g/ml; see Figure 4 ). This antiserum had no 10% of baseline). If multimerization of PICK1-GluR2/3 or PICK1-PKC␣ complexes is required for LTD inducsignificant effect on the amplitude of basal quisqualate pulses (104% Ϯ 6% of baseline at t ϭ 15 min, n ϭ 7), tion, then one would predict that application of an excess mutant GST-PICK1 fusion protein in which the PDZ nor did it effect the amplitude, frequency, or kinetics of AMPA-mEPSCs (Table 1) . However, it did produce a domain had been rendered nonfunctional might function as a dominant-negative for this process as it could multistrong blockade of LTD induction (95% Ϯ 7% of baseline at t ϭ 55 min). Two control experiments indicate that merize with native PICK1 but not bind GluR2/3 or PKC␣. When this protein (GST-PICK1⌬PDZ, 50 g/ml, n ϭ 6) the blockade of LTD induction by this antiserum results from a specific action at the PICK1 PDZ domain. First, was infused into Purkinje cells, no significant alteration in baseline responses to test pulses of quisqualate was preabsorption of the antiserum with the PICK1 PDZ domain peptide used for its generation resulted in a comseen (99% Ϯ 5% of baseline at t ϭ 17.5 min), but the amplitude of subsequent LTD induction was signifiplete reversal of the LTD-blocking effect (59% Ϯ 9% of baseline at t ϭ 55 min, n ϭ 6). Second, perfusion of an cantly reduced (83% Ϯ 10% of baseline at t ϭ 55 min). To this point, we have shown that treatments that affinity-purified antiserum directed against the nonneuronal protein rapsyn, had no effect on LTD induction interfere with the interaction between PICK1 and GluR2/3 or PICK1 multimerization produce a strong (53% Ϯ 9% of baseline at t ϭ 55 min, n ϭ 5).
How might binding of PICK1 to GluR2/3 trigger LTD? blockade of cerebellar LTD. One concern in ascribing causality to these observations is that these treatments In addition to its amino-terminal PDZ domain, which can bind GluR2/3 and PKC␣, PICK1 has a coiled-coil domain might have side effects on other processes known to be required for LTD induction. their ability to bind GRIP/ABP), both produced a strong baseline at t ϭ 45 min, n ϭ 4, dynCONTROL: 50% Ϯ 9% of baseline, n ϭ 4). Thus, LTD induced by quisqualate/ blockade of PDA-induced depression (phospho-SVKI: 88% Ϯ 9% of baseline at t ϭ 45 min, n ϭ 6; SVAI: 92% Ϯ depolarization conjunction and depression of AMPA responses by an exogenous PKC activator both require 9% of baseline, n ϭ 5). Furthermore, anti-N-PICK1 antiserum produced a similar blockade 108% Ϯ 7% of base-PICK1-GluR2/3 interactions and clathrin-mediated endocytosis. line, n ϭ 6), which was prevented when the antiserum was preabsorbed with PICK1 N-terminal PDZ domain peptide (45% Ϯ 8% of baseline, n ϭ 5).
Discussion Previous work has shown that cerebellar LTD induced by conjunctive stimulation is blocked by treatments that
The main finding of this study is that treatments that block interactions between the carboxy-terminal PDZ interfere with clathrin-mediated endocytosis such as perfusion of a peptide based on the proline-rich domain binding motif of GluR2/3 and PICK1 strongly attenuate the expression of cerebellar LTD in cultured Purkinje of dynamin I (Wang and Linden, 2000). As GluR2 carboxy-terminal PDZ domain interactions are regulated cells. These manipulations include three different peptides based upon the GluR2 PDZ binding motif (but not by PKC, we sought to determine if depression induced by the PKC activator PDA also requires clathrin-median inactive control) and an antiserum directed against the amino-terminal PDZ domain of PICK1 (but not a ated endocytosis. Therefore, the aforementioned dynamin peptide (dynaminPRD, 100 g/ml) was perfused preabsorbed control; see Figures 3 and 4) . In addition, treatments that potentially interfere with PICK1-GluR2/3 into Purkinje cells prior to bath application of PDA. The dynamin PRD peptide, but not a scrambled control (dynmultimerization blocked LTD induction ( Figure 5 ). These treatments are likely to be exerting their effects through CONTROL, 100 g/ml) produced a strong blockade of PDA-induced depression (dynaminPRD: 90% Ϯ 9% of disruption of PICK1-GluR2/3 interactions rather than side effects because they did not affect the basal func-(H. J. Chung et al., submitted), and (3), in a heterologous expression system, mutation of GluR2 Ser-880 to alation of AMPA receptors (Figure 2 and Table 1), voltagegated Ca 2ϩ channels or mGluR1 (Figure 6 ). Thus, blocknine prevented phorbol ester-induced GluR2 internalization (H. J. Chung et al., submitted). However, there ade of PICK1-GluR2/3 interactions attenuates cerebellar LTD expression in a manner that is independent of the are several caveats that also should be mentioned. First, the present experiments were done using immature Purinitial signals known to be required for its induction.
While the GluR2/3 carboxy-terminal PDZ binding motif kinje cells in culture and so one must always be concerned that the cellular mechanisms underlying cerebelcan interact with both PICK1 and GRIP/ABP, the finding that two different treatments (phospho-SVKI peptide lar LTD might be different in intact, adult tissue. Second, the prior observation that phorbol ester treatment of and anti-N-PICK1 antiserum) that block PICK1 but not GRIP/ABP interactions attenuate LTD (Figures 3 and 4 show that internal application binding to GluR2/3 also occurs, thereby stabilizing the internal pool and attenuating compensatory insertion of of SVKI and phospho-SVKI GluR2 peptides, but not an SVKA control, attenuates LTD at the Schaffer collateral-AMPA receptors (see Figure 8B) . Importantly, in both of these models, application of reagents that block either CA1 synapse in a slice preparation. Furthermore, in separate experiments using field potential recording, LTD PICK1-GluR2/3 or GRIP/ABP-GluR2/3 interactions (or both) would not be expected to alter the basal response induction was associated with an increase in Ser-880- and GluR␦2. However, at present, no differences have
